Assessment of vision is a challenging but important component of the evaluation of patients with multiple sclerosis (MS), neuromyelitis optica spectrum disorder (NMOSD), and myelin oligodendroctye glycoprotein antibody-associated disorder (MOGAD).
This session will highlight the assessment of optic neuritis, distinguishing between MS, NMOSD and MOGAD, will explore the role of optical coherence tomography (OCT) in the evaluation of demyelinating disorders, and will revisit the question of whether to treat patients with a clinically isolated syndrome (CIS).
[learn_press_profile]